Medicine and Dentistry
Adolescent
11%
Antibiotic Therapy
13%
Antibiotics
20%
Asthma
65%
Atopy
7%
Body Mass Index
5%
Breathing
5%
Childbirth
21%
Chronic Obstructive Pulmonary Disease
7%
Clinician
5%
Cohort Analysis
8%
Cohort Effect
18%
Coughing
9%
Cystic Fibrosis
100%
Disease
24%
Forced Expiratory Volume
39%
Forced Vital Capacity
12%
Functional Residual Capacity
5%
Growth, Development and Aging
5%
Infancy
6%
Lower Respiratory Tract
11%
Lung Development
5%
Lung Function
17%
Maximal Expiratory Flow
5%
Nitric Oxide
5%
Observational Study
5%
Obstructive Sleep Apnea
9%
Odds Ratio
5%
Patient Registry
7%
Patient with Cystic Fibrosis
19%
Pediatrics
16%
Physical Disease by Body Function
6%
Placebo
7%
Polysomnography
6%
Preschooler
8%
Pseudomonas
5%
Pseudomonas aeruginosa
13%
Randomized Clinical Trial
8%
Respiratory Disease
14%
Silo-Filler's Disease
9%
Spirometry
11%
Sputum
7%
Symptom
17%
Toddlers
13%
Wheeze
34%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotic Agent
10%
Antibiotics
12%
Asthma
66%
Chronic Obstructive Lung Disease
6%
Coughing
7%
Cystic Fibrosis
74%
Disease
17%
Dornase Alfa
9%
Epidemiology
11%
Immunoglobulin E
5%
Lung Disease
5%
Mild Persistent Asthma
6%
Observational Study
8%
Omalizumab
6%
Physical Disease by Body Function
7%
Placebo
11%
Randomized Clinical Trial
8%
Respiratory Tract
7%
Respiratory Tract Disease
8%
Salbutamol
10%
Sleep Disordered Breathing
6%
Symptom
12%
Wheezing
24%
Keyphrases
Antibiotic Treatment
5%
Asthma
20%
Asthma Control
5%
Cystic Fibrosis
44%
Decline in Lung Function
7%
Decline Rate
7%
Dornase Alfa
7%
Early childhood
5%
Epidemiologic Studies
6%
Fluticasone Propionate
5%
Forced Expiratory Volume in 1 Second (FEV1)
31%
Inhaled Corticosteroids
8%
Intravenous Antibiotics
5%
Lower Respiratory Tract Infection
6%
Lung Function
20%
Preschool children
6%
Pulmonary Exacerbation
13%
Risk Factors
5%
Theophylline
6%
Tucson
11%
Wheezing
10%
